Ackman Wields Finance Tool With Morbid Past for New Venture (Bloomberg) Bill Ackman is putting a modern-day spin on a centuries-old financial innovation...
Keep Reading →
July 8 - Hedge Funds, Insider Trading - Comments
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish...
Keep Reading →
July 8 - Hedge Funds, News - Comments
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data....
Keep Reading →
June 4 - Hedge Funds, News - Comments
Coronavirus is probably the #1 concern in investors’ minds right now. It should be. On February 27th we published an article with the title Recession...
Keep Reading →
May 4 - Hedge Funds, News - Comments
Coronavirus is probably the #1 concern in investors’ minds right now. It should be. On February 27th we publish an article with the title “Recession...
Keep Reading →
March 11 - Hedge Funds, News - Comments
We are still in an overall bull market and many stocks that smart money investors were piling into surged in 2019. Among them, Facebook and Microsoft...
Keep Reading →
December 26 - Hedge Funds, News - Comments
Last year’s fourth quarter was a rough one for investors and many hedge funds, which were naturally unable to overcome the big dip in the broad...
Keep Reading →
December 3 - Hedge Funds, News - Comments
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 750...
Keep Reading →
October 15 - Hedge Funds, News - Comments
Is Incyte Corporation (NASDAQ:INCY) a good stock to buy right now? We at Insider Monkey like to examine what billionaires and hedge funds think of a company...
Keep Reading →
June 13 - Hedge Funds, News - Comments
Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying before the Q4 market crash that the stock market is overvalued due...
Keep Reading →
April 1 - Hedge Funds, News - Comments
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They...
Keep Reading →
December 10 - Hedge Funds, News - Comments
Tesla Motors Inc (NASDAQ:TSLA) CEO Elon Musk has made amends with investors of his company after a poorly handled earnings call last week sent shares...
Keep Reading →
May 8 - Insider Trading, News, Tech - Comments
1. U.S. Stock Market: “Stocks rose on Wall Street on Thursday, capping a wave of declines in major world equity markets triggered by uncertainty...
Keep Reading →
May 18 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech - Comments
1. US Stock Market: “U.S. equities rose on Monday as a weekend filled with geopolitical worries ended more calmly than investors expected, while...
Keep Reading →
April 17 - Commodities, Gold, Market Movers, News, Tech - Comments
Traders are watching Incyte Corporation (NASDAQ:INCY) after Geoff Meacham of Barclays hiked his price target on the biotech to $185 per share from $...
Keep Reading →
April 7 - News - Comments
If, back in 2013, you invested in at least one of the 11 fastest growing S&P 500 companies in America, chances are that you are one happy (and possibly...
Keep Reading →
April 4 - Lists, News - Comments
The market has been volatile due to elections and the potential of another Federal Reserve rate increase. Small cap stocks have been on a tear, as the...
Keep Reading →
November 28 - Hedge Funds, News - Comments
Baker Bros. Advisors is a fund managed by Julian Baker and Felix Baker that mainly invests in biotechnology companies, and today we are going to take...
Keep Reading →
November 14 - Hedge Funds, News - Comments
Which are the most successful innovative companies in the world in 2016? Bringing something new to the table is something that seems to be difficult these...
Keep Reading →
October 26 - Hedge Funds, Lists, News - Comments
While several hedge funds have suffered enormous losses this year due to their investments in biotech stocks, the performance of the leading biotech-focused...
Keep Reading →
May 7 - Hedge Fund Analysis, Hedge Funds, News - Comments
It is generally believed that individuals seeking to become millionaires (and who isn’t?) need to think and act like millionaires. That’s probably...
Keep Reading →
March 18 - Hedge Funds, News - Comments
Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker. The firm focuses on life science and biotechnology companies...
Keep Reading →
February 25 - Hedge Funds, News - Comments
Baker Bros. Advisors is one of the most famous healthcare-focused equity hedge funds in the world today. It was founded in 2000 by brothers Julian Baker...
Keep Reading →
December 9 - Hedge Fund Analysis, Hedge Funds, News - Comments
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity...
Keep Reading →
December 1 - Hedge Funds, News - Comments
As the markets are mixed on Tuesday, fueled by a surge in oil prices, among the crowd of stocks moving in different directions, shares of Encana Corporation...
Keep Reading →
October 6 - Market Movers, News - Comments
Eli Lilly and Co (NYSE:LLY) and Incyte Corporation (NASDAQ:INCY) are experiencing volatility at Tuesday’s open, initially moving in different directions...
Keep Reading →
September 29 - Market Movers, News - Comments
With the rapid pace of M&A happening in the biotechnology sector, Julian Baker and Felix Baker‘s Baker Bros. Advisors is making a habit of hitting...
Keep Reading →
July 10 - Hedge Funds, News - Comments
Julian Baker and Felix Baker‘s Baker Bros. Advisors’ top pick from the end of 2014 has paid off for the fund in a big way in 2015. AbbVie Inc...
Keep Reading →
March 5 - Hedge Funds, News - Comments
Julian and Felix Baker‘s Baker Bros. Advisors has decreased its stake in MEI Pharma Inc (NASDAQ:MEIP) to 746,521 shares, from 1,130,317 shares...
Keep Reading →
January 2 - Hedge Funds, News - Comments
Julian and Felix Baker and their hedge fund, Baker Bros. Advisors, reported slicing their exposure at Incyte Corporation (NASDAQ:INCY) to 19.53 million...
Keep Reading →
November 15 - Hedge Funds, News - Comments
Is Theravance Inc (NASDAQ:THRX) a good investment? At the moment, there are many indicators investors can use to analyze stocks. Some of the most under...
Keep Reading →
September 12 - News - Comments
Analyst downgrades are a dime a dozen. They often move stocks, but few are what I would consider good calls. Historically, analysts have a tendency to...
Keep Reading →
September 11 - News - Comments
At the moment, there are a multitude of metrics shareholders can use to monitor stocks. A pair of the most useful are hedge fund and insider trading sentiment...
Keep Reading →
September 10 - News - Comments
Earlier this month, I wrote an article explaining that I liked Incyte Corporation (NASDAQ:INCY) on the basis of the blockbuster potential of its only...
Keep Reading →
September 6 - News - Comments
As an investor in the health care sector, it can sometimes feel like everything — and everyone — is out to get you. The ongoing threat of...
Keep Reading →
August 30 - News - Comments
Should investors be bullish on Incyte Corporation (NASDAQ:INCY)? In the 21st century investor’s toolkit, there are many gauges shareholders can use...
Keep Reading →
August 30 - News - Comments
In the financial world, there are many methods shareholders can use to track stocks. A couple of the most innovative are hedge fund and insider trading...
Keep Reading →
August 27 - News - Comments
In today’s marketplace, there are a multitude of gauges market participants can use to analyze their holdings. Two of the most innovative are hedge...
Keep Reading →
August 27 - News - Comments
While the overall market muddled through the past five days, some stocks were on fire. Here are three health-care stocks experiencing humongous gains...
Keep Reading →
August 26 - News - Comments
With the SPDR S&P Biotech Index up 37% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into...
Keep Reading →
August 25 - News - Comments
Is Medivation Inc (NASDAQ:MDVN) a buy? In today’s marketplace, there are a multitude of methods shareholders can use to monitor the equity markets....
Keep Reading →
August 25 - News - Comments
There’s been plenty of buzz lately about the continuing saga of the possible buyout of Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) by Amgen, Inc. (...
Keep Reading →
August 23 - News - Comments
The phase 2 data that Incyte Corporation (NASDAQ:INCY) presented on Wednesday was downright stellar. For a subgroup of the patients, the hazard ratio...
Keep Reading →
August 23 - News - Comments
While I do think it’s possible that MannKind Corporation (NASDAQ:MNKD)‘s inhaled insulin device, Afrezza, will be approved by the Food and...
Keep Reading →
August 22 - News - Comments
One of the hottest stocks on the market Wednesday was Incyte Corporation (NASDAQ:INCY), a pharmaceutical company specializing in the development of JAK...
Keep Reading →
August 22 - News - Comments
Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes — just in case...
Keep Reading →
August 21 - News - Comments
Editor’s Note: Incyte Corporation (NASDAQ:INCY), Diamond Foods, Inc. (NASDAQ:DMND), Organovo Holdings Inc (NYSEMKT:ONVO) Incyte Rises Most in...
Keep Reading →
August 21 - News - Comments
Incyte Corporation (NASDAQ:INCY) today announced positive results from a phase 2 study of its drug Jakafi in treating refractory metastatic pancreatic...
Keep Reading →
August 21 - News - Comments
The buyout drama surrounding cancer drug maker Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) is really beginning to heat up, and it’s offering investors...
Keep Reading →
August 16 - News - Comments
Budding biotech company Incyte Corporation (NASDAQ:INCY), which specializes in developing novel JAK inhibitors, released solid second-quarter earnings...
Keep Reading →
August 1 - News - Comments
